QTRX (Quanterix) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 24, 2026)


QTRX Quanterix Corp QTRX
58 GF Score
Price $3.68
GF Value $11.62
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Quanterix Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Quanterix's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

QTRX vs SNWV, CVRX, NNOX: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Devices subindustry, Quanterix's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Quanterix Margin of Safety % (DCF Earnings Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Quanterix's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Quanterix's Margin of Safety % (DCF Earnings Based) falls into.


QTRX
58GF Score
Quanterix Corp QTRX
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Quanterix (QTRX) Overvalued in 2026?

Based on GuruFocus' analysis, Quanterix stock appears to be undervalued. The current stock price of $3.68 is trading 68.4% below its estimated GF Value™ of $11.62. GuruFocus considers Quanterix to be Possible Value Trap.

Key valuation signals for QTRX:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: $11.62 vs. price of $3.68 (68.4% below fair value)
  • GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the QTRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Quanterix Business Description

Address 900 Middlesex Turnpike, Billerica, MA, USA, 01821
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.
58GF Score

Get the complete analysis for QTRX

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.68
Price
$11.62
GF Value